146 related articles for article (PubMed ID: 38706601)
1. The prognostic value of co-expression of stemness markers CD44 and CD133 in endometrial cancer.
Jiang P; Tian C; Zheng Y; Gong C; Wang J; Liu Y
Front Oncol; 2024; 14():1338908. PubMed ID: 38706601
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of cancer stem cell related markers CD44 and CD133 in endometrial cancer.
Elbasateeny SS; Salem AA; Abdelsalam WA; Salem RA
Pathol Res Pract; 2016 Jan; 212(1):10-6. PubMed ID: 26608413
[TBL] [Abstract][Full Text] [Related]
3. Expression of the potential cancer stem cell markers CD133 and CD44 in medullary thyroid carcinoma: A ten-year follow-up and prognostic analysis.
Bi Y; Meng Y; Wu H; Cui Q; Luo Y; Xue X
J Surg Oncol; 2016 Feb; 113(2):144-51. PubMed ID: 26799258
[TBL] [Abstract][Full Text] [Related]
4. A Nomogram Model for Predicting Recurrence of Stage I-III Endometrial Cancer Based on Inflammation-Immunity-Nutrition Score (IINS) and Traditional Classical Predictors.
Jiang P; Wang J; Gong C; Yi Q; Zhu M; Hu Z
J Inflamm Res; 2022; 15():3021-3037. PubMed ID: 35645577
[TBL] [Abstract][Full Text] [Related]
5. Tumour stem cell markers CD133 and CD44 are useful prognostic factors after surgical resection of pancreatic neuroendocrine tumours.
Sun Z; Li D; Wu H; Hou B
Oncol Lett; 2020 Dec; 20(6):341. PubMed ID: 33123252
[TBL] [Abstract][Full Text] [Related]
6. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma.
Chen S; Hou JH; Feng XY; Zhang XS; Zhou ZW; Yun JP; Chen YB; Cai MY
J Surg Oncol; 2013 Jun; 107(8):799-806. PubMed ID: 23609373
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of proliferative, migratory and multidrug-resistant endometrial carcinoma-initiating cells from human type II endometrial carcinoma cell lines.
Gao Y; Liu T; Cheng W; Wang H
Oncol Rep; 2012 Aug; 28(2):527-32. PubMed ID: 22581025
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved.
Lu L; Wu M; Sun L; Li W; Fu W; Zhang X; Liu T
Medicine (Baltimore); 2016 Oct; 95(42):e5163. PubMed ID: 27759647
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data.
Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M
Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019
[TBL] [Abstract][Full Text] [Related]
11. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of stem cell surface markers CD133, CD24, and CD44 in colorectal cancer.
Huang JL; Oshi M; Endo I; Takabe K
Am J Cancer Res; 2021; 11(10):5141-5154. PubMed ID: 34765317
[TBL] [Abstract][Full Text] [Related]
13. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of CD44-positive/CD133-positive cancer stem cells and CD204-positive tumor-associated macrophages is a predictor of survival in pancreatic ductal adenocarcinoma.
Hou YC; Chao YJ; Tung HL; Wang HC; Shan YS
Cancer; 2014 Sep; 120(17):2766-77. PubMed ID: 24839953
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of CD133
Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Hu J; Li Y; Mo X; Zhou Z
Cancer Med; 2017 Dec; 6(12):2850-2857. PubMed ID: 29105339
[TBL] [Abstract][Full Text] [Related]
16. [Clinical application of adult comorbidity evaluation-27 in endometrial cancer].
Tian WY; Wang YM; Yan Y; Gao JP; Sun DD; Jiang S; Sheng Y; Teng F; Xue FX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):810-817. PubMed ID: 27916063
[No Abstract] [Full Text] [Related]
17. Consistency of P53 immunohistochemical expression between preoperative biopsy and final surgical specimens of endometrial cancer.
Zhang J; Jiang P; Gong C; Kong W; Tu Y; Huang Y; Liu Y
Front Oncol; 2023; 13():1240786. PubMed ID: 37700829
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and Clinical Value of CD44 and CD133 in Esophageal Cancer: A Systematic Review and Meta-analysis.
Kamil Mohammed Al-Mosawi A; Cheshomi H; Hosseinzadeh A; M Matin M
Iran J Allergy Asthma Immunol; 2020 Apr; 19(2):105-116. PubMed ID: 32372624
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression-ALDH1A1, CD133, CD44-For Survival and Long-Term Follow-Up of Ovarian Cancer Patients.
Izycka N; Rucinski M; Andrzejewska M; Szubert S; Nowak-Markwitz E; Sterzynska K
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768723
[TBL] [Abstract][Full Text] [Related]
20. Association Between CD133, CD44, and Nestin Expression and Prognostic Factors in High-Grade Meningioma.
Kamamoto D; Saga I; Ohara K; Yoshida K; Sasaki H
World Neurosurg; 2018 Dec; ():. PubMed ID: 30593958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
